-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Redefining Approaches in Early-Line Multiple Myeloma Treatment

Sponsor: Janssen Biotech, Inc
Program: Product Theaters
Sunday, December 6, 2020: 11:00 AM-12:00 PM
Redefining Approaches in Early-Line Multiple Myeloma Treatment

Kathleen Gray, PhD

Janssen Scientific Affairs, Horsham, PA
See more of: Product Theaters
<< Previous Product Theater | Next Product Theater >>